Does Nebulized Epinephrine Cause Hypokalemia?
Yes, nebulized epinephrine can cause hypokalemia, though the effect is primarily documented with systemic (intravenous) administration rather than inhaled formulations, and the clinical significance with nebulized use appears minimal.
Mechanism of Hypokalemia
Epinephrine induces hypokalemia through β2-adrenergic receptor stimulation, which activates membrane-bound Na+/K+-ATPase pumps, driving potassium intracellularly 1, 2. This effect is:
- Dose-dependent: Significant hypokalemia typically occurs at plasma epinephrine concentrations of approximately 1,300-1,700 pg/mL, achieved with IV infusions of 160-320 ng/kg/min 3
- β2-receptor specific: Selective β2-antagonists (ICI 118551) completely block epinephrine-induced hypokalemia, while β1-selective antagonists (atenolol) provide only partial protection 4, 2
- Clinically significant: Serum potassium can drop by 0.6-0.8 mEq/L with systemic epinephrine administration 1, 4
Nebulized vs. Systemic Epinephrine
The critical distinction is route of administration:
- Nebulized epinephrine (used for croup at 0.5 mL/kg of 1:1000 solution) produces primarily local airway effects with minimal systemic absorption 5
- The FDA-approved inhaled epinephrine formulation does not list hypokalemia as a recognized adverse effect 6
- Systemic (IV) epinephrine produces substantial plasma concentrations that reliably cause hypokalemia 1, 4, 3
Clinical Context: Other Bronchodilators
Beta-2 agonist bronchodilators (the class most relevant to your question) DO cause hypokalemia:
- Nebulized metaproterenol caused a mean decline of 0.6 mEq/L in mechanically ventilated patients 7
- Theophylline (methylxanthine) causes dose-related hypokalemia as a recognized adverse effect 5
- This is a class effect of β2-agonists, not unique to epinephrine 8
Clinical Monitoring Recommendations
Monitor potassium levels when:
- Using high-dose or continuous nebulized β2-agonists in acute severe asthma 5
- Patients are on concurrent medications that lower potassium (diuretics, insulin) 8
- Baseline hypokalemia exists (increases arrhythmia risk) 8
- Using systemic epinephrine infusions (>0.1 mcg/kg/min), where hypokalemia is expected 1, 3
Important Caveats
Sudden discontinuation of epinephrine infusions can paradoxically cause life-threatening hyperkalemia as potassium shifts back extracellularly—taper epinephrine gradually in critically ill patients 9. Additionally, critically ill children receiving epinephrine infusions >0.3 mcg/kg/min have increased risk of gastrointestinal complications, though this relates to shock states rather than potassium effects directly 10.
For standard nebulized epinephrine use (such as for croup), hypokalemia is not a clinically significant concern and routine potassium monitoring is unnecessary 5, 6.